U.S. Proceeds with Boosters and Mixing COVID-19 Vaccinations

The US Centers for Disease Control and Prevention (CDC) vaccine advisory committee unanimously voted in the affirmative late on October 21, 2021, supporting booster vaccinations for the SpikeVax COVID-19 vaccine from Moderna and the Janssen COVID-19 vaccine from Johnson & Johnson.

Additionally, the CDC's vaccine committed embraced the option of "mixing and matching" between the three Authorized/Approved COVID-19 vaccines in the U.S.

The CDC committee's two-day meeting presentations are available at this link.

The CDC committee and Director previously approved the Comirnaty vaccine from Pfizer-BioNTech. And the US Food and Drug Administration had already authorized such authorizations.

As of October 21, 2021, the CDC data dashboard reported about 57.2% of eligible persons in the U.S. are fully vaccinated.